Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications locations anaphylactic events schools observed 2014 2015 epipen4schools® survey
Medicare Drug Price Negotiation (DPN): Implications for Industry Share on: June 26, 2024 Contributed by: Shahnaz Khan, MPH Vice President, Value & Access RTI Health Solutions Now is the time for drug manufacturers to do everything they can to get ready …
… spearheaded more than 30 evidence generation projects and publications. …
Grant Stafford Pharmacoepidemiology and Risk Management Barcelona, Spain MPH, Public Health Pompeu Fabra University, Barcelona, Spain BSc, Business Miami University Farmers School of Business, Oxford, OH Grant Stafford, MPH, is a Research Epidemiologist …
New Real-World Evidence of Effective Treatment in Non-Small-Cell Lung Cancer with Capmatinib Share on: February 27, 2023 Non-small cell lung cancer (NSCLC) is an aggressive disease, with poor prognosis and a high likelihood of brain metastases. Overall …
Anita Tormos Pharmacoepidemiology and Risk Management Barcelona, Spain MPH, Humanitarian Health and Epidemiology EHESP School of Public Health, Paris, France BSc, Biomedical Sciences Brunel University, London, United Kingdom Anita Tormos, MPH, is a …
Ashley Davis recognized for Best General Podium Research Presentation Award at ISPOR 2022 Share on: June 8, 2022 Image Congratulations to Ashley Davis, PhD, Director, Health Economics at RTI Health Solutions (RTI-HS), for being awarded Best General …
… advisory board of the journal Value in Health for November 2014 to November 2022. …
Andrea Margulis Pharmacoepidemiology and Risk Management Women's Health Diabetes & Endocrine Disorders Telecommuter - Germany ScD, Epidemiology ScM, Epidemiology Harvard University, Boston, MA Specialist in Pediatrics MD University of Buenos Aires, Buenos …
Assess Long-Term Treatment Effects with Pooled Database Analysis Share on: November 27, 2023 For drug and biotech developers, understanding long-term treatment effects is an important part of evaluating the benefit-risk balance of their products. …
FDA’s Sentinel Initiative Driving Sound Research Practices for COVID-19 Vaccine Development Share on: November 11, 2021 RTI-HS is collaborating with the FDA to ensure that rigorous, valid methods are used to evaluate COVID-19 vaccine effectiveness in the …